RGRX Insider Trading Activity and SEC Form 4 Filings
RGRX insider trading summary
No open-market insider purchases or sales of Regenerx Biopharmaceuticals Inc (RGRX) have been reported on SEC Form 4 in the past 12 months.
Latest RGRX insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Jun 30, 2021 | J J Finkelstein | President and CEO | Buy | $15K (75,000 @ $0.20) |
| Jun 30, 2021 | Paolo Cavazza | 10% Owner | Buy | $300K (1,500,000 @ $0.20) |
| Jun 30, 2021 | Allan L Goldstein | Director | Buy | $25K (125,000 @ $0.20) |
| Mar 13, 2018 | Francesca Cavazza | 10% Owner | Buy | $2.7M (11,584,795 @ $0.23) |
| Mar 13, 2018 | Preta Martina Cavazza | 10% Owner | Buy | $2.7M (11,584,795 @ $0.23) |
| Mar 13, 2018 | Paolo Cavazza | 10% Owner | Buy | $1.5M (6,348,878 @ $0.23) |
| Mar 13, 2018 | Enrico Cavazza | 10% Owner | Buy | $1.5M (6,348,878 @ $0.23) |
| Mar 13, 2018 | Francesca Cavazza | 10% Owner | Buy | $1.5M (6,348,878 @ $0.23) |
| Mar 13, 2018 | Silvia Cavazza | 10% Owner | Buy | $1.5M (6,348,878 @ $0.23) |
| Mar 13, 2018 | SPA Essetifin | 10% Owner | Buy | $2.7M (11,584,795 @ $0.23) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.